Related Experiment Video
Updated: Feb 10, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Unraveling AMPK and BET regulation of immune checkpoint biology: implications for personalized medicine
Abstract:
Triple negative breast cancer (TNBC) patients with comorbid Type 2 diabetes (T2D) show worse survival compared to nondiabetic TNBC patients. Immune checkpoint blockade (ICB) has unclear benefit in TNBC. Immune suppression in T2D, and use of metformin, an activator of 5' Adenosine Monophosphate-activated Protein Kinase (AMPK), in such patients, prompted us to examine AMPK regulation of immune checkpoint expression. Improved ICB efficacy may optimize outcomes for certain TNBC patients. We have also been exploring the role of Bromodomain and ExtraTerminal domain (BET) proteins (BRD2, BRD3, BRD4) in regulation of checkpoint molecules in immune cell subsets, including CD4+, CD8+ T cells, and NK cells. BET proteins are important transcriptional co-regulators, critical for proliferation and metastasis in many cancer types, including TNBC. We observed differential BET regulation of immune checkpoint proteins, specifically TIM-3, TIGIT, PD-1 and CTLA-4, on αCD3/αCD28-stimulated peripheral blood mononuclear cells by flow cytometry. Chemical inhibition of AMPK with Compound C, and with the pan-BET inhibitor JQ1 or the BRD4-selective PROTAC inhibitor MZ-1, revealed that BET proteins regulate PD-1 and CTLA-4 through an AMPK-dependent pathway and TIM-3 and TIGIT through an AMPK-independent pathway. Personalized approaches to ICB treatment of TNBC patients with comorbid T2D should improve outcomes.
Insights
Triple negative breast cancer (TNBC) patients with type 2 diabetes (T2D) have poorer outcomes. Bromodomain and ExtraTerminal domain (BET) proteins and 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) influence immune checkpoints, potentially improving immunotherapy for TNBC with T2D.
Area of Science:
- Immunology
- Oncology
- Metabolic Disease
Background:
- Triple negative breast cancer (TNBC) patients with type 2 diabetes (T2D) exhibit worse survival rates.
- The efficacy of immune checkpoint blockade (ICB) in TNBC is not well-defined.
- Type 2 diabetes (T2D) is associated with immune suppression, and metformin's activation of 5' Adenosine Monophosphate-activated Protein Kinase (AMPK) warrants investigation into AMPK's role in immune checkpoint regulation.
Purpose of the Study:
- To investigate the role of AMPK and Bromodomain and ExtraTerminal domain (BET) proteins in regulating immune checkpoint expression in TNBC.
- To explore potential therapeutic strategies for improving ICB efficacy in TNBC patients, particularly those with comorbid T2D.
Main Methods:
- Utilized flow cytometry to analyze immune checkpoint protein expression (TIM-3, TIGIT, PD-1, CTLA-4) on stimulated peripheral blood mononuclear cells.
- Employed chemical inhibition of AMPK (Compound C) and BET proteins (pan-BET inhibitor JQ1, BRD4-selective PROTAC inhibitor MZ-1) to assess their regulatory pathways.
Main Results:
- BET proteins differentially regulate immune checkpoint proteins TIM-3, TIGIT, PD-1, and CTLA-4.
- BET proteins regulate PD-1 and CTLA-4 via an AMPK-dependent pathway.
- BET proteins regulate TIM-3 and TIGIT via an AMPK-independent pathway.
Conclusions:
- BET proteins and AMPK play distinct roles in regulating immune checkpoints relevant to TNBC.
- Targeting BET proteins and AMPK pathways may offer personalized therapeutic strategies to enhance ICB efficacy in TNBC patients with T2D.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
What is Conservation Biology?
What is the Immune System?
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...

